 | • レポートコード：20QY06-05532 • 出版社/出版日：QYResearch / 2020年6月3日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、136ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、抗薬物のグローバル市場について種類別（多価抗毒素、一価抗毒素）、用途別（小売薬局、病院、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・抗薬物市場の概要 ・世界の主要地域別抗薬物市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の抗薬物市場規模2015-2026：種類別（多価抗毒素、一価抗毒素） ・世界の抗薬物市場規模2015-2026：用途別（小売薬局、病院、その他） ・抗薬物の北米市場規模2015-2020 ・抗薬物のヨーロッパ市場規模2015-2020 ・抗薬物の中国市場規模2015-2020 ・抗薬物の日本市場規模2015-2020 ・抗薬物の東南アジア市場規模2015-2020 ・抗薬物のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （CSL Behring、Merck & Co.、BTG Plc、Pfizer、Haffkine Bio-Pharmaceutical Corporation、Rare Disease Therapeutics、Flynn Pharma、Vins Bioproducts、Bharat Serums and Vaccines、Serum Biotech） ・抗薬物の製造コスト分析 ・販売チャネル、流通業者、顧客 ・抗薬物の市場動向・機会・課題 ・調査の結論 |
Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are only recommended if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.
Asia-Pacific Antivenom market is valued at 285.00 million USD in 2017 and is expected to reach 359.23 million USD by the end of 2023, growing at a CAGR of 43.93% between 2016 and 2022.
Market Analysis and Insights: Global Antivenom Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Antivenom market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Antivenom industry.
Based on our recent survey, we have several different scenarios about the Antivenom YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 873.6 million in 2019. The market size of Antivenom will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Antivenom Scope and Market Size
The global Antivenom market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antivenom market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Antivenom market is segmented into
Polyvalent antivenom
Monovalent antivenom
Segment by Application, the Antivenom market is segmented into
Retail Pharmacies
Hospitals
Others
The Antivenom market is analysed and market size information is provided by regions (countries). Segment by Application, the Antivenom market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Antivenom Market Share Analysis
Antivenom market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Antivenom business, the date to enter into the Antivenom market, Antivenom product introduction, recent developments, etc.
The major vendors covered:
CSL Behring
Merck & Co.
BTG Plc
Pfizer
Haffkine Bio-Pharmaceutical Corporation
Rare Disease Therapeutics
Flynn Pharma
Vins Bioproducts
Bharat Serums and Vaccines
Serum Biotech
1 Antivenom Market Overview
1.1 Antivenom Product Scope
1.2 Antivenom Segment by Type
1.2.1 Global Antivenom Sales by Type (2020-2026)
1.2.2 Polyvalent antivenom
1.2.3 Monovalent antivenom
1.3 Antivenom Segment by Application
1.3.1 Global Antivenom Sales Comparison by Application (2020-2026)
1.3.2 Retail Pharmacies
1.3.3 Hospitals
1.3.4 Others
1.4 Antivenom Market Estimates and Forecasts (2015-2026)
1.4.1 Global Antivenom Sales Growth Rate (2015-2026)
1.4.2 Global Antivenom Revenue and Growth Rate (2015-2026)
1.4.3 Global Antivenom Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Antivenom Industry Impact
1.5.1 How the Covid-19 is Affecting the Antivenom Industry
1.5.1.1 Antivenom Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Antivenom Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Antivenom Players to Combat Covid-19 Impact
2 Antivenom Estimate and Forecast by Region
2.1 Global Antivenom Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Antivenom Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Antivenom Sales Market Share by Region (2015-2020)
2.2.2 Global Antivenom Revenue Market Share by Region (2015-2020)
2.3 Global Antivenom Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Antivenom Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Antivenom Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Antivenom Estimates and Projections (2015-2026)
2.4.2 Europe Antivenom Estimates and Projections (2015-2026)
2.4.3 China Antivenom Estimates and Projections (2015-2026)
2.4.4 Japan Antivenom Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Antivenom Estimates and Projections (2015-2026)
2.4.6 India Antivenom Estimates and Projections (2015-2026)
3 Global Antivenom Competition Landscape by Players
3.1 Global Top Antivenom Players by Sales (2015-2020)
3.2 Global Top Antivenom Players by Revenue (2015-2020)
3.3 Global Antivenom Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antivenom as of 2019)
3.4 Global Antivenom Average Price by Company (2015-2020)
3.5 Manufacturers Antivenom Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Antivenom Players (Opinion Leaders)
4 Global Antivenom Market Size by Type
4.1 Global Antivenom Historic Market Review by Type (2015-2020)
4.1.1 Global Antivenom Sales Market Share by Type (2015-2020)
4.1.2 Global Antivenom Revenue Market Share by Type (2015-2020)
4.1.3 Global Antivenom Price by Type (2014-2020)
4.2 Global Antivenom Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Antivenom Sales Forecast by Type (2021-2026)
4.2.2 Global Antivenom Revenue Forecast by Type (2021-2026)
4.2.3 Global Antivenom Price Forecast by Type (2021-2026)
5 Global Antivenom Market Size by Application
5.1 Global Antivenom Historic Market Review by Application (2015-2020)
5.1.1 Global Antivenom Sales Market Share by Application (2015-2020)
5.1.2 Global Antivenom Revenue Market Share by Application (2015-2020)
5.1.3 Global Antivenom Price by Application (2015-2020)
5.2 Global Antivenom Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Antivenom Sales Forecast by Application (2021-2026)
5.2.2 Global Antivenom Revenue Forecast by Application (2021-2026)
5.2.3 Global Antivenom Price Forecast by Application (2021-2026)
3 North America Antivenom Market Facts & Figures
3.2 North America Antivenom Sales Market Share by Company (2015-2020)
3.3 North America Antivenom Sales Market Share by Type (2015-2020)
3.4 North America Antivenom Sales Market Share by Application (2015-2020)
4 Europe Antivenom Market Facts & Figures
4.2 Europe Antivenom Sales Market Share by Company (2015-2020)
4.3 Europe Antivenom Sales Market Share by Type (2015-2020)
4.4 Europe Antivenom Sales Market Share by Application (2015-2020)
5 China Antivenom Market Facts & Figures
5.2 China Antivenom Sales Market Share by Company (2015-2020)
5.3 China Antivenom Sales Market Share by Type (2015-2020)
5.4 China Antivenom Sales Market Share by Application (2015-2020)
6 Japan Antivenom Market Facts & Figures
6.2 Japan Antivenom Sales Market Share by Company (2015-2020)
6.3 Japan Antivenom Sales Market Share by Type (2015-2020)
6.4 Japan Antivenom Sales Market Share by Application (2015-2020)
7 Southeast Asia Antivenom Market Facts & Figures
7.2 Southeast Asia Antivenom Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Antivenom Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Antivenom Sales Market Share by Application (2015-2020)
8 India Antivenom Market Facts & Figures
8.2 India Antivenom Sales Market Share by Company (2015-2020)
8.3 India Antivenom Sales Market Share by Type (2015-2020)
8.4 India Antivenom Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Antivenom Business
12.1 CSL Behring
12.1.1 CSL Behring Antivenom Corporation Information
12.1.2 CSL Behring Antivenom Business Overview and Total Revenue
12.1.3 CSL Behring Antivenom Sales, Revenue and Gross Margin (2015-2020)
12.1.4 CSL Behring Antivenom Products Offered
12.1.5 CSL Behring Recent Development
12.2 Merck & Co.
12.2.1 Merck & Co. Antivenom Corporation Information
12.2.2 Merck & Co. Antivenom Business Overview and Total Revenue
12.2.3 Merck & Co. Antivenom Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Merck & Co. Antivenom Products Offered
12.2.5 Merck & Co. Recent Development
12.3 BTG Plc
12.3.1 BTG Plc Antivenom Corporation Information
12.3.2 BTG Plc Antivenom Business Overview and Total Revenue
12.3.3 BTG Plc Antivenom Sales, Revenue and Gross Margin (2015-2020)
12.3.4 BTG Plc Antivenom Products Offered
12.3.5 BTG Plc Recent Development
12.4 Pfizer
12.4.1 Pfizer Antivenom Corporation Information
12.4.2 Pfizer Antivenom Business Overview and Total Revenue
12.4.3 Pfizer Antivenom Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Pfizer Antivenom Products Offered
12.4.5 Pfizer Recent Development
12.5 Haffkine Bio-Pharmaceutical Corporation
12.5.1 Haffkine Bio-Pharmaceutical Corporation Antivenom Corporation Information
12.5.2 Haffkine Bio-Pharmaceutical Corporation Antivenom Business Overview and Total Revenue
12.5.3 Haffkine Bio-Pharmaceutical Corporation Antivenom Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Haffkine Bio-Pharmaceutical Corporation Antivenom Products Offered
12.5.5 Haffkine Bio-Pharmaceutical Corporation Recent Development
12.6 Rare Disease Therapeutics
12.6.1 Rare Disease Therapeutics Antivenom Corporation Information
12.6.2 Rare Disease Therapeutics Antivenom Business Overview and Total Revenue
12.6.3 Rare Disease Therapeutics Antivenom Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Rare Disease Therapeutics Antivenom Products Offered
12.6.5 Rare Disease Therapeutics Recent Development
12.7 Flynn Pharma
12.7.1 Flynn Pharma Antivenom Corporation Information
12.7.2 Flynn Pharma Antivenom Business Overview and Total Revenue
12.7.3 Flynn Pharma Antivenom Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Flynn Pharma Antivenom Products Offered
12.7.5 Flynn Pharma Recent Development
12.8 Vins Bioproducts
12.8.1 Vins Bioproducts Antivenom Corporation Information
12.8.2 Vins Bioproducts Antivenom Business Overview and Total Revenue
12.8.3 Vins Bioproducts Antivenom Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Vins Bioproducts Antivenom Products Offered
12.8.5 Vins Bioproducts Recent Development
12.9 Bharat Serums and Vaccines
12.9.1 Bharat Serums and Vaccines Antivenom Corporation Information
12.9.2 Bharat Serums and Vaccines Antivenom Business Overview and Total Revenue
12.9.3 Bharat Serums and Vaccines Antivenom Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Bharat Serums and Vaccines Antivenom Products Offered
12.9.5 Bharat Serums and Vaccines Recent Development
12.10 Serum Biotech
12.10.1 Serum Biotech Antivenom Corporation Information
12.10.2 Serum Biotech Antivenom Business Overview and Total Revenue
12.10.3 Serum Biotech Antivenom Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Serum Biotech Antivenom Products Offered
12.10.5 Serum Biotech Recent Development
13 Antivenom Manufacturing Cost Analysis
13.1 Antivenom Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Antivenom
13.4 Antivenom Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Antivenom Distributors List
14.3 Antivenom Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Antivenom Sales (K Vials) Growth Rate by Type (2020-2026)
Table 2. Global Antivenom Sales (K Vials) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Antivenom Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Antivenom Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Antivenom Players to Combat Covid-19 Impact
Table 8. Global Market Antivenom Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Antivenom Sales (K Vials) by Region (2015-2020)
Table 10. Global Antivenom Sales Market Share by Region (2015-2020)
Table 11. Global Antivenom Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Antivenom Revenue Share by Region (2015-2020)
Table 13. Global Antivenom Sales (K Vials) Forecast by Region (2021-2026)
Table 14. Global Antivenom Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Antivenom Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Antivenom Revenue Share Forecast by Region (2021-2026)
Table 17. Global Antivenom (K Vials) of Key Companies (2015-2020)
Table 18. Global Antivenom Sales Share by Company (2015-2020)
Table 19. Global Antivenom Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Antivenom Revenue Share by Company (2015-2020)
Table 21. Global Antivenom by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antivenom as of 2019)
Table 22. Global Antivenom Average Price (USD/Vial) of Key Company (2015-2020)
Table 23. Manufacturers Antivenom Manufacturing Sites and Area Served
Table 24. Manufacturers Antivenom Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Antivenom Players
Table 27. Global Antivenom Sales (K Vials) by Type (2015-2020)
Table 28. Global Antivenom Sales Share by Type (2015-2020)
Table 29. Global Antivenom Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Antivenom Price (K Vials) by Type (2015-2020)
Table 31. Global Antivenom Sales Share by Type (2021-2026)
Table 32. Global Antivenom Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Antivenom Revenue Share by Type (2021-2026)
Table 34. Global Antivenom Price (K Vials) by Type (2021-2026)
Table 35. Global Antivenom Sales (K Vials) by Application (2015-2020)
Table 36. Global Antivenom Sales Share by Application (2015-2020)
Table 37. Global Antivenom Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Antivenom Price (K Vials) by Application (2015-2020)
Table 39. Global Antivenom Sales (K Vials) by Application (2021-2026)
Table 40. Global Antivenom Sales Share by Application (2021-2026)
Table 41. Global Antivenom Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Antivenom Revenue Share by Application (2021-2026)
Table 43. Global Antivenom Price (K Vials) by Application (2021-2026)
Table 44. United States Antivenom Sales (K Vials) by Company (2015-2020)
Table 45. United States Antivenom Sales Market Share by Company (2015-2020)
Table 46. United States Antivenom Sales (K Vials) by Type (2015-2020)
Table 47. United States Antivenom Sales Market Share by Type (2015-2020)
Table 48. United States Antivenom Sales (K Vials) by Application (2015-2020)
Table 49. United States Antivenom Sales Market Share by Application (2015-2020)
Table 50. Europe Antivenom Sales (K Vials) by Company (2015-2020)
Table 51. Europe Antivenom Sales Market Share by Company (2015-2020)
Table 52. Europe Antivenom Sales (K Vials) by Type (2015-2020)
Table 53. Europe Antivenom Sales Market Share by Type (2015-2020)
Table 54. Europe Antivenom Sales (K Vials) by Application (2015-2020)
Table 55. Europe Antivenom Sales Market Share by Type (2015-2020)
Table 56. China Antivenom Sales (K Vials) by Company (2015-2020)
Table 57. China Antivenom Sales Market Share by Company (2015-2020)
Table 58. China Antivenom Sales (K Vials) by Type (2015-2020)
Table 59. China Antivenom Sales Market Share by Type (2015-2020)
Table 60. China Antivenom Sales (K Vials) by Application (2015-2020)
Table 61. China Antivenom Sales Market Share by Application (2015-2020)
Table 62. Japan Antivenom Sales (K Vials) by Company (2015-2020)
Table 63. Japan Antivenom Sales Market Share by Company (2015-2020)
Table 64. Japan Antivenom Sales (K Vials) by Type (2015-2020)
Table 65. Japan Antivenom Sales Market Share by Type (2015-2020)
Table 66. Japan Antivenom Sales (K Vials) by Application (2015-2020)
Table 67. Japan Antivenom Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Antivenom Sales (K Vials) by Company (2015-2020)
Table 69. Southeast Asia Antivenom Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Antivenom Sales (K Vials) by Type (2015-2020)
Table 71. Southeast Asia Antivenom Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Antivenom Sales (K Vials) by Type (2015-2020)
Table 73. Southeast Asia Antivenom Sales Market Share by Application (2015-2020)
Table 74. India Antivenom Sales (K Vials) by Company (2015-2020)
Table 75. India Antivenom Sales Market Share by Company (2015-2020)
Table 76. India Antivenom Sales (K Vials) by Type (2015-2020)
Table 77. India Antivenom Sales Market Share by Type (2015-2020)
Table 78. India Antivenom Sales (K Vials) by Application (2015-2020)
Table 79. India Antivenom Sales Market Share by Application (2015-2020)
Table 80. CSL Behring Corporation Information
Table 81. CSL Behring Description and Business Overview
Table 82. CSL Behring Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2015-2020)
Table 83. CSL Behring Antivenom Product
Table 84. CSL Behring Recent Development
Table 85. Merck & Co. Corporation Information
Table 86. Merck & Co. Description and Business Overview
Table 87. Merck & Co. Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2015-2020)
Table 88. Merck & Co. Antivenom Product
Table 89. Merck & Co. Recent Development
Table 90. BTG Plc Corporation Information
Table 91. BTG Plc Description and Business Overview
Table 92. BTG Plc Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2015-2020)
Table 93. BTG Plc Antivenom Product
Table 94. BTG Plc Recent Development
Table 95. Pfizer Corporation Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2015-2020)
Table 98. Pfizer Antivenom Product
Table 99. Pfizer Recent Development
Table 100. Haffkine Bio-Pharmaceutical Corporation Corporation Information
Table 101. Haffkine Bio-Pharmaceutical Corporation Description and Business Overview
Table 102. Haffkine Bio-Pharmaceutical Corporation Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2015-2020)
Table 103. Haffkine Bio-Pharmaceutical Corporation Antivenom Product
Table 104. Haffkine Bio-Pharmaceutical Corporation Recent Development
Table 105. Rare Disease Therapeutics Corporation Information
Table 106. Rare Disease Therapeutics Description and Business Overview
Table 107. Rare Disease Therapeutics Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2015-2020)
Table 108. Rare Disease Therapeutics Antivenom Product
Table 109. Rare Disease Therapeutics Recent Development
Table 110. Flynn Pharma Corporation Information
Table 111. Flynn Pharma Description and Business Overview
Table 112. Flynn Pharma Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2015-2020)
Table 113. Flynn Pharma Antivenom Product
Table 114. Flynn Pharma Recent Development
Table 115. Vins Bioproducts Corporation Information
Table 116. Vins Bioproducts Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2015-2020)
Table 117. Vins Bioproducts Description and Business Overview
Table 118. Vins Bioproducts Antivenom Product
Table 119. Vins Bioproducts Recent Development
Table 120. Bharat Serums and Vaccines Corporation Information
Table 121. Bharat Serums and Vaccines Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2015-2020)
Table 122. Bharat Serums and Vaccines Description and Business Overview
Table 123. Bharat Serums and Vaccines Antivenom Product
Table 124. Bharat Serums and Vaccines Recent Development
Table . Serum Biotech Corporation Information
Table . Serum Biotech Description and Business Overview
Table . Serum Biotech Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2015-2020)
Table . Serum Biotech Antivenom Product
Table . Serum Biotech Recent Development
Table 130. Production Base and Market Concentration Rate of Raw Material
Table 131. Key Suppliers of Raw Materials
Table 132. Antivenom Distributors List
Table 133. Antivenom Customers List
Table 134. Market Key Trends
Table 135. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 136. Key Challenges
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Antivenom Product Picture
Figure 2. Global Antivenom Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Antivenom Market Share by Application in 2020 & 2026
Figure 6. Retail Pharmacies Examples
Figure 7. Hospitals Examples
Figure 8. Others Examples
Figure 9. Global Antivenom Sales (K Vials) Growth Rate (2015-2026)
Figure 10. Global Antivenom Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Antivenom Price Trends Growth Rate (2015-2026) (USD/Vial)
Figure 12. Global Antivenom Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Antivenom Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Antivenom Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Antivenom Sales (K Vials) Growth Rate (2015-2026)
Figure 16. Europe Antivenom Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Antivenom Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Antivenom Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Antivenom Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Antivenom Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Antivenom Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Antivenom Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Antivenom Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Antivenom Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Antivenom Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Antivenom Players Market Share by Revenue in Antivenom 2015 & 2019
Figure 27. Antivenom Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Antivenom Revenue Share by Type (2015-2020)
Figure 29. Global Antivenom Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Antivenom Revenue Share by Application (2015-2020)
Figure 31. Global Antivenom Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Antivenom Sales Market Share by Type in 2019
Figure 33. United States Antivenom Sales Market Share by Type in 2019
Figure 34. Europe Antivenom Sales Market Share by Company in 2019
Figure 35. Europe Antivenom Sales Market Share by Type in 2019
Figure 36. Europe Antivenom Sales Market Share by Application in 2019
Figure 37. China Antivenom Sales Market Share by Company in 2019
Figure 38. China Antivenom Sales Market Share by Type in 2019
Figure 39. China Antivenom Sales Market Share by Application in 2019
Figure 40. Japan Antivenom Sales Market Share by Company in 2019
Figure 41. Japan Antivenom Sales Market Share by Type in 2019
Figure 42. Japan Antivenom Sales Market Share by Application in 2019
Figure 43. Southeast Asia Antivenom Sales Market Share by Company in 2019
Figure 44. Southeast Asia Antivenom Sales Market Share by Type in 2019
Figure 45. Southeast Asia Antivenom Sales Market Share by Application in 2019
Figure 46. India Antivenom Sales Market Share by Company in 2019
Figure 47. India Antivenom Sales Market Share by Type in 2019
Figure 48. India Antivenom Sales Market Share by Application in 2019
Figure 49. CSL Behring Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Merck & Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. BTG Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Haffkine Bio-Pharmaceutical Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Rare Disease Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Flynn Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Vins Bioproducts Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Bharat Serums and Vaccines Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Serum Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Key Raw Materials Price Trend
Figure 60. Manufacturing Cost Structure of Antivenom
Figure 61. Manufacturing Process Analysis of Antivenom
Figure 62. Antivenom Industrial Chain Analysis
Figure 63. Channels of Distribution
Figure 64. Distributors Profiles
Figure 65. Porter's Five Forces Analysis
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
抗毒血清の世界市場レポート2020 Market Analysis and Insights: Global Antivenom Serum Market The global Antivenom Serum market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Antivenom Serum Scope and Market Size The global Antivenom Serum mark…- 多価肺炎球菌ワクチンの世界市場レポート2020 Pneumococcal vaccines are vaccines against the bacteria Streptococcus pneumoniae. Their use can prevent some cases of pneumonia, meningitis, and sepsis. Market Analysis and Insights: Global Pneumococcal Vaccine Polyvalent Market The global Pneumococcal Vaccine Polyvalent market was valued at US$ xx …
- プラズマエキスパンダーの世界市場レポート2020 Plasma expanders are agents that have high molecular weight and that boost the plasma volume by increasing the osmotic pressure. After administration, plasma expanders remain for an enough time to restore the volume of the circulatory fluid by increasing the osmotic pressure. Increased government fu…
- 麻疹・おたふく風邪・風疹（MMR）用ワクチンの世界市場レポート2020 A recently published report by QY Research titled Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statisti…
- 避妊薬の世界市場レポート2020 Contraceptives are a kind of medicine used to prevent unwanted pregnancy. It consists of one or more synthetic female sex hormones. These sex hormones prevent pregnancy by blocking the normal process of ovulation. In the next five years, the global consumption of Contraceptives will maintain more th…